Improved biocompatibility by modified cellulosic membranes: the case of hemophan.
The rising problem of biocompatibility is encouraging the development of new dialysis membranes, but the high cost of synthetic ones precludes their wide use. The authors compared the biocompatibility of cuprophan (CU), cellulose acetate (CA), and hemophan (HE), evaluating both in vitro and in vivo polymorphonuclear leukocyte (PMN) oxidative metabolism activation by resting chemiluminescence and complement activation by C3a; in vivo PMN counts during dialysis were also performed. The lowest increase in in vitro PMN resting chemiluminescence using HE was + 71.3% with CA, +49.3% with CU, and + 21.4% with HE (p less than 0.001 versus CA and CU); furthermore, HE did not significantly stimulate PMN resting chemiluminescence during in vivo hemodialysis: + 56.6% with CA, + 38.8% with CU, and + 3.7% with HE (p less than 0.01 versus CU and p less than 0.001 versus CA). C3a concentration increased with all membranes both in vitro and in vivo, but HE (in both experimental conditions) showed the lowest increase at any time (p less than 0.001 versus CA and CU). After 15 min of dialysis, PMN count dropped to 20.3% of basal values with CU, to 49.8% with CA, and to 76.5% with HE (p less than 0.001 versus CU and CA). Among cellulosic membranes, HE is the most biocompatible and appears to be an important step in preventing blood-membrane interactions and related complications.
Lucchi
L
L
Department of Nephrology and Dialysis, University Hospital, Modena, Italy.
Bonucchi
D
D
Acerbi
M A
MA
Cappelli
G
G
Spattini
A
A
Innocenti
M
M
Castellani
A
A
Lusvarghi
E
E
D001672:Biocompatible Materials; D002482:Cellulose / Q000031:analogs & derivatives*; D003167:Complement Activation; D006801:Humans; D007970:Leukopenia / Q000517:prevention & control; D006435:Renal Dialysis / Q000191:economics / Q000295:instrumentation
D001672:Biocompatible Materials; C054645:Hemophan; D002482:Cellulose